Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
Hamer
Davidson H
DH
Gill
Christopher J
CJ
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004351:Drug Resistance; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D011634:Public Health; D012307:Risk Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage* / Q000494:pharmacology
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination